Supernus Pharmaceuticals, Inc.: Supernus Announces FDA Approval of ONAPGO (apomorphine hydrochloride) for Parkinson's Disease
ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson's diseaseONAPGO is a wearable subcutaneous infusion devi ...
manilatimes2h
Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson's Disease
ONAPGO is a prescription medicine used to treat motor fluctuations (OFF episodes) in adults with advanced Parkinson's disease (PD). It is not known if ONAPGO is safe and effective in children. Do not ...
The Lancet16h
Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: a population-based study
Estimated geographical and temporal distribution of lung-cancer incidence varied across the four main subtypes worldwide. Our ...
Thirdhand smoke lingers in homes, posing hidden health risks for years
You likely know about the health risks associated with smoking, probably even secondhand smoke, but have you heard of ...
Times-News6hOpinion
How Idaho's ancient horse fossils reveal a 3.5-million-year mystery | Curious mind
Hagerman Valley Historical Society clarifies origins of its prehistoric horse skeleton replica, announces museum expansion to ...
What's on Netflix17h
Welcome to What's on Netflix
Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...